GAD antibodies in neurological disease: a critical evaluation of the utility and treatment implications of GAD antibodies in clinical practice

Brown, Rachel L.; Thomas-Black, Gilbert; Garcia-Moreno, Hector; Chou, Michael; Fleszar, Zofia; Zandi, Michael S.; Chapman, Miles; Church, Andrew J.; Hart, Melanie; Giunti, Paola; Vincent, Angela; Lunn, Michael P.

dc.contributor.author	Fleszar, Zofia Maria
dc.date.accessioned	2025-11-18T09:54:38Z
dc.date.available	2025-11-18T09:54:38Z
dc.date.issued	2025
dc.identifier.issn	0340-5354
dc.identifier.uri	http://hdl.handle.net/10900/172324
dc.language.iso	en	de_DE
dc.publisher	Heidelberg : Springer Heidelberg	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s00415-025-12926-3	de_DE
dc.subject.ddc	610	de_DE
dc.title	GAD antibodies in neurological disease: a critical evaluation of the utility and treatment implications of GAD antibodies in clinical practice	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250630000000_01438
utue.personen.roh	Brown, Rachel L.
utue.personen.roh	Thomas-Black, Gilbert
utue.personen.roh	Garcia-Moreno, Hector
utue.personen.roh	Chou, Michael
utue.personen.roh	Fleszar, Zofia
utue.personen.roh	Zandi, Michael S.
utue.personen.roh	Chapman, Miles
utue.personen.roh	Church, Andrew J.
utue.personen.roh	Hart, Melanie
utue.personen.roh	Giunti, Paola
utue.personen.roh	Vincent, Angela
utue.personen.roh	Lunn, Michael P.
dcterms.isPartOf.ZSTitelID	Journal of Neurology	de_DE
dcterms.isPartOf.ZS-Issue	Article 222	de_DE
dcterms.isPartOf.ZS-Volume	272 (3)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE